Cell free DNA analysis vs sequential screening as primary testing considering all fetal chromosomal abnormalities

被引：8
|
作者：
Norton, Mary [1 ]
Wapner, Ronald [2 ]
Kuppermann, Miriam [1 ]
Jelliffe-Pawlowski, Laura [3 ]
Currier, Robert [3 ]
机构：
[1] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Div Maternal Fetal Med, San Francisco, CA USA
[2] Columbia Univ, Med Ctr, Obstet & Gynecol, New York, NY USA
[3] Calif Dept Publ Hlth, Genet Dis Screening Program, Richmond, CA USA
来源：
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY | 2015年 / 212卷 / 01期
关键词：
D O I：
10.1016/j.ajog.2014.10.033
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
2
引用
收藏
页码：S2 / S2
页数：1
相关论文
共 50 条
  • [1] Cell-free DNA vs sequential screening for the detection of fetal chromosomal abnormalities
    Norton, Mary E.
    Baer, Rebecca J.
    Wapner, Ronald J.
    Kuppermann, Miriam
    Jelliffe-Pawlowski, Laura L.
    Currier, Robert J.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2016, 214 (06)
  • [2] Cell-free DNA vs sequential screening for the detection of fetal chromosomal abnormalities
    Benn, Peter
    Norwitz, Errol R.
    Pergament, Eugene
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2016, 215 (02) : 252 - 253
  • [3] Cell-free DNA vs sequential screening for the detection of fetal chromosomal abnormalities REPLY
    Norton, Mary E.
    Kuppermann, Miriam
    Jelliffe-Pawlowski, Laura L.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2016, 215 (02) : 253 - 254
  • [4] Cell-Free DNA vs Sequential Screening for the Detection of Fetal Chromosomal Abnormalities EDITORIAL COMMENT
    Norton, Mary E.
    Baer, Rebecca J.
    Wapner, Ronald J.
    Kuppermann, Miriam
    Jelliffe-Pawlowski, Laura L.
    Currier, Robert J.
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2016, 71 (10) : 576 - 578
  • [5] Cell-free DNA versus sequential screening for fetal chromosomal abnormalities varied by age: a cost-effectiveness analysis
    Doshi, Uma
    Avram, Carmen M.
    Caughey, Aaron B.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2023, 228 (01) : S756 - S756
  • [6] Cell-free DNA test for fetal chromosomal abnormalities in multiple pregnancies
    Kwan, Angel H. W.
    Gil, Maria Mar
    Xue, Shuwen
    Kwok, Yvonne K. Y.
    Lau, Doris
    Fung, Joanna
    Chan, Andrea
    Choy, Kwong Wai
    Leung, Tak Yeung
    Poon, Liona C.
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2024, 103 (09) : 1799 - 1807
  • [7] Benefits of contingent screening vs primary screening by cell-free DNA testing: think again
    Oepkes, D.
    Bartha, J. L.
    Schmid, M.
    Yaron, Y.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2016, 47 (05) : 542 - 545
  • [8] Chromosomal abnormalities not currently detected by cell-free fetal DNA: a retrospective analysis at a single center
    Shani, Hagit
    Goldwaser, Tamar
    Keating, Jennifer
    Klugman, Susan
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2016, 214 (06) : 729.e1 - 729.e11
  • [9] The price of abandoning diagnostic testing for cell free fetal DNA screening
    Evans, Mark I.
    Evans, Shara M.
    Bennett, Terri-Ann
    Wapner, Ronald J.
    PRENATAL DIAGNOSIS, 2019, 39 (02) : 131 - 132
  • [10] Role of cell-free fetal DNA in the maternal plasma in the prenatal diagnosis of chromosomal abnormalities
    Lu, Rong
    Xu, Hui
    Chen, Xin
    Wang, Yuanlin
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (06): : 11740 - 11747
12345